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Abstract
Background: Methyl-CpG-binding protein 2 (MeCP2) is a key transcriptional regulator of gene expression in the
maintenance and development of the central nervous system. Loss- or gain-function of this gene may contribute to
neurodevelopmental disorders. The aim of this study is to delineate the clinical characteristics of MECP2 duplication
syndrome and the hereditary mechanism in a Chinese family.
Case presentation: We identified a Chinese family with three persons carry MECP2 gene duplication: a boy, his mother
and his grandmother. The duplication segment which was detected by multiplex ligation-dependent probe amplification
(MLPA) included gene MECP2, interleukin-1 receptor-associated kinase 1 (IRAK1), filamin A (FLNA), and L1 cell adhesion
molecule (L1CAM). Furthermore, array comparative genomic hybridization (aCGH) was performed on the mother, showed
that MECP2 containing duplication was 510 Kb (153,113,885-153,624,154), including 16 other genes except MECP2. The
boy showed most symptoms of MECP2 duplication syndrome. His mother and maternal grandmother were
asymptomatic. Both female carriers had a skewed X chromosome inactivation (XCI), which were 80:20 and 74:26
respectively.
Conclusion: To our knowledge, this is the second reported Chinese Han family with MECP2-containing duplications.
And this patient had recurrent respiratory infections which was different from the first two Chinese-brother cases.
MECP2 is the core gene responsible for MECP2 duplication syndrome. XCI may play an important role in modulating
the clinical manifestation.
Keywords: MECP2 duplication syndrome, Chinese family, MLPA, aCGH, Skewed X chromosome inactivation
Background
Methyl-CpG-binding protein 2 (MECP2) located at Xq28
acts as a transcriptional repressor or activator regulating
the genes associated with nerve system development [1].
Loss-of-function mutations of MECP2 gene are the cause
of most cases of Rett syndrome (RTT, OMIM: 312750).
RTT is a neurodevelopmental disorder which affects 1/
10,000 girls. Recent studies found that duplications involv-
ing MECP2 gene and increased MECP2 protein dosage
can cause a severe syndromic developmental delay (DD),
mental retardation (MR), and recurrent infections. It was
found in 1 % of patients with idiopathic X-linked MR
(XLMR) and in 2 % of male patients with severe encephal-
opathy [2]. It was named MECP2 duplication syndrome
(MECP2 DS), a newly described genetic condition, and
gain-of-function mutations ofMECP2.
The cardinal features of the syndrome include early on-
set hypotonia, moderate to profound mental retardation,
delayed psychomotor development, speech delay or absent
to very limited speech, seizures, progressive spasticity in
male patients. Dysmorphism is common and some fea-
tures changed with age. Midface hypoplasia, depressed
nasal bridge and a hypotonic face such as open mouth
with tented upper lip, excessive drooling present in most
patients at young age. When time goes by, some add-
itional facial features may appear: a narrow nose, promin-
ent chin, deep-set eyes, large ears, and widely spaced teeth
[3]. Genital anomalies, including cryptorchidism and small
penis, were reported in some cases. Patients with congeni-
tal central hypoventilation syndrome (CCHS), hyperkin-
esis were also reported [4, 5]. Half of these patients have a
short lifespan less than 25-year-old [6]. The animal model
with over expression both the mouse and human MECP2
gene showed similar neurological symptoms including
epilepsy, spasticity, hypoactivity and short lifespan. The
* Correspondence: zwhang@pku.edu.cn
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severe phenotype is correlated with the higher Mecp2 pro-
tein level [7, 8].
Here we report a Chinese boy with MECP2 duplication
syndrome, who inherited the duplicated gene from his un-
affected mother, while his mother inherited the duplicated
gene from his unaffected grandmother. The genetic char-
acters and the clinical features are presented.
Case presentation
Case report
The patient is a 2-year-4-month-old boy, who is the first
child of his nonconsanguineous Chinese parents, a 26-
year-old mother and a 27-year-old father, both of them
are healthy. Following an uneventful pregnancy, he was
born at 38 weeks of gestation with a birth weight of
3.15 kg. Feeding difficulties and poor suck had been no-
ticed since birth. Hypotonia was apparent at age of
4 months. He showed severe developmental delay. He
could not raise his head until 4 months old, sit unsup-
ported till 11 months. At 2-year-4-month-old, he could
not walk and speak any meaningful words. Eye contact
and social smiling were enabling. He had recurrent re-
spiratory tract infections, and hospitalized for severe
pneumonia for several times. At 12 months old, his head
circumference was 47 cm, weight was 11 kg. The boy had
mild dysmorphism with flat nasal bridge, anteverted nares,
small mouth, high-arched palate, low-set ears and crypt-
orchidism of the right side. Hand stereotypes including
hand wringing and hand shaking presented at 8 months.
He had no chronic constipation, no seizures. Magnetic
resonance imaging (MRI) at age 1 year was unremarkable.
Karyotype analysis was normal. Serum amino acid and
urine organic acid screen were unremarkable.
Family history: The boy’s mother had two younger
brothers. Both of them had severe developmental delay.
The elder one could not walk or speak before he died at
age of 5. The best motor function was sitting unaided. His
brain computed tomography (CT) scan showed general-
ized cerebral atrophy. The younger one had a history of
recurrent infections, died of a sever pneumonia at the age
of 1y. He could not sit or walk alone during his life, speak
no meaningful words yet. Both the mother and the grand-
mother were asymptomatic, they did not have any symp-
toms of depression, anxiety and compulsions. Figure 1
showed the pedigrees of the family, the proband was
showed by an arrow.
MLPA tests
Genomic DNAs from the peripheral blood leukocytes of
the patient, his parents and the maternal grandmother
were extracted using standard methods. MLPA (SALSA
MLPA kit P015 MECP2, MRC-Holland, Amsterdam,
Holland) was performed to detect large deletions or du-
plications of MECP2 gene as previously described [9].
MLPA products were separated and analyzed using the
ABI Prism 3100 Genetic Analyzer and Genescan soft-
ware according to manufacturer’s recommendations.
aCGH analysis
In order to determine the precise size of the duplication,
aCGH was performed on the mother’ DNA, using
Affymetrix GeneChip System 3000Dx v.2 (by Tianjin
kingmed center for clinical laboratory, Shanghai, China).
Fluorescence in situ hybridization (FISH)
FISH test was performed to interrogate the MECP2 copy
number and to identify the location of the duplicated
MECP2 gene in chromosome (done by Beijing Ahngook
Pharm. Co., Ltd, Beijing, China).
X chromosome inactivation patterns (XCI)
The patterns of XCI of female carriers were analyzed ac-
cording to the procedure described by Allen et al. [10].
Inactivation was considered to be non- random if the ra-
tio was > 70:30.
Results
DNA fragment duplication was found in the patient, his
mother and maternal grandmother by MLPA test. The
fragment range from X-152,783,270 to X-153,239,085,
including L1 cell adhesion molecule gene (L1CAM;
OMIM #308840), interleukin-1 receptor-associated kinase
1 (IRAK1; OMIM #300283), MECP2, filamin A (FLNA;
OMIM #300017) and other genes, that probes were not
designed in the kit P015 (Fig. 2).
aCGH was performed on the proband’s mother to test
the precise size of the duplicated fragment. The result
showed that the duplication fragment was 510, 270 bps
(153,113,885–153,624,154) containing 17 genes (Table 1),
Fig. 1 Pedigrees of the family. III-1 is the proband, I-1 and II-1 carry
the MECP2 duplication, II-2 and II-3 died at the age of 5-year-old and
the age of 1y, respectively
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Fig. 2 Genes duplication in the proband (a), his mother (b) and his grandmother (c), tested by MLPA
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including two subunits of Micro-RNA (MIR3202), start-
ing from L1CAM and ending with emerin (EMD;
OMIM #300384). There was no gene coming across the
breakpoints.
FISH test was performed on the mother. The red
fluorescence signals representing MECP2 gene were seen
on each X chromosome, and only one fluorescence sig-
nal could be seen on each X chromosome (Fig. 3). That
means the duplicated MECP2 gene was located at X
chromosome next to the original MECP2 gene.
The XCI pattern analysis showed the XCI ratio of the
patient’s mother and maternal grandmother was 80:20
and 74:26, respectively. The X chromosome carrying the
duplication was 80 % inactive in the mother and 74 %
inactive in the grandmother. The proband inherited the
X chromosome carrying the duplication variant from his
mother.
Discussion
With the development of new techniques, some genomic
disorders such as Williams-Beuren syndrome (WBS, MIM
194050), Potocki-Lupski syndrome (PTLS, MIM 610883),
Miller-Dieker syndrome (MDS, MIM 247200), were found
to be caused by the alteration of gene dosage, or copy
number variation (CNV) [11]. MECP2 gene acting as a
transcriptional regulator of gene expression should ex-
press very accurate level in cells. Loss-of-function of
MECP2 leads to Rett syndrome while gain-of-function
causes MECP2 duplication syndrome. In additional,
patient with Xq28 rearrangement containing MECP2 trip-
lication was considered to be more severe than MECP2
duplication [12, 13]. Animal models also demonstrated
this phenomenon.
MECP2 duplication is most common among the Xq28
rearrangement. The reported duplications differed in
size and location (except the carrier mom and inherited
Table 1 Duplicated genes and their positions
Gene Position
L1 cell adhesion molecule (L1CAM) X:153,126,969–153,141,500
Arginine vasopressin receptor 2 (AVPR2) X:153,170,428–153,172,620
Rho GTPase activating protein 4 (ARHGAP4) X:153,172,830–153,191,714
N (alpha)-acetyltransferase 10 (NAA10) X:153,195, 280–153,200,607
Renin binding protein (RENBP) X:153,200,722–153,210,232
Host cell factor C1 (HCFC1) X:153,213,008–153,236,819
Transmembrane protein 187 (TMEM187) X:153,237,991–153,248,646
MicroRNA 3202–1 (MIR3202-1a) X:153,246,548–153,246,628
MicroRNA 3202–2 (MIR3202-2a) X:153,246,549–153,246,627
Interleukin-1 receptor-associated kinase 1 (IRAK1) X:153,275,957–153,285,342
MicroRNA 718 (MIR718) X:153,285,371-153,285,440
Methyl CpG binding protein 2 (MECP2) X:153,287,264–153,363,188
Opsin 1 (cone pigments), long-wave-sensitive (OPN1LW) X:153,409,725–153,424,507
Opsin 1 (cone pigments), medium-wave-sensitive (OPN1MW) X:153,485,203–153,499,470
Testis expressed 28 (TEX28) X:153,498,929–153,523,563
Transketolase-like 1 (TKTL1) X: 153,524,027–153,558,713
Filamin A, alpha (FLNA) X:153,576,900–153,603,006
Emerin (EMD) X:153,607,597–153,609,883
aTwo subunits of micro-RNA3202
Fig. 3 Two-color fluorescence in situ hybridization analysis of the
mother with MECP2 gene duplication. The duplicated MECP2 gene
was located at X chromosome, and only one fluorescence signal can
be seen on each X chromosome. Green signal is a control single-copy
probe, hybridized to alpha satellite DNA at the chromosome X
centromere. Red signal on distal Xq is a probe for the MECP2 gene,
which is present on each X chromosome
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offspring), were defined as non-recurrent events. The
flanking region around MECP2 gene is abundant of low-
copy repeat (LCR) sequences and high GC content, which
generated the genomic instability such as double-strand
breaks (DSBs) and a collapsed fork. The molecular mecha-
nisms of MECP2 copy number variation were proposed
by mainly two ways: one is Fork Stalling and Template
Switching (FoSTeS), another is microhomology mediated
break-induced replication (MMBIR) [14–17].
In the previous reports, the sizes of the duplications
encompassing MECP2 locus vary between 79.7 kbs and
15.5 Mbs [18, 19]. The smallest duplication only contains
MECP2 and IRAK1 genes. The duplication size in our pa-
tient was about 510 kbs, including 17 genes, starting from
L1CAM and ending with EMD. L1CAM, IRAK1, MECP2
and FLNA were embraced in the duplication. These four
genes play important roles in postnatal nervous system
development. L1CAM and MECP2 were associated with X-
linked mental retardation (XLMD). IRAK1, encoding an
interleukin receptor–associated kinase was involved in the
toll–like receptor transduction pathway, was a critical sig-
naling mediator of innate immunity. Gottipati et al. found
that over expression of this gene might lead to the suscepti-
bility to infections [20]. However, Yang and colleagues iden-
tified immune defects among the patients with MECP2 DS
had no association with IRAK1 duplication by transgenic
mice that overexpressed MECP2 without IRAK1 duplica-
tion [21]. This conclusion was supported by Sawalha [22].
Chronic intestinal pseudo–obstruction (CIPO), thrombcy-
topaenia, patent ductus arteriosus (PDA), malrotation were
found in two families with the duplications involved only
the FLNA gene [23]. One case suffered CCHS also had
chronic constipation without duplication of FLNA [24].
Some other genes in the duplicated area of our patient may
be associated with mental retardation and development
delay. Huang et al. reported 2 male-dizygotic-twins with a
17.9-kbs deletion of Xq28 including Arginine vasopressin
receptor-2 gene (AVPR2; OMIM 300538) and extending
into intron 7 of the RHO GTPase-activating protein 4 gene
(ARHGAP4; OMIM 300023). They were diagnosed with
nephrogenic diabetes insipidus (NDI) as well as psycho-
motor developmental delay [25]. Host cell factor C1 gene
(HCFC1; OMIM 300019) was reported to be associated
with X-linked mental retardation (XLMR) [26]. The clinical
manifestation of our patient was characterized by develop-
mental delay, early hypotonia, recurrent infection, and mild
dysmorphism, without CIPO, PDA and NDI. Combined
our study and previous reports, most of the symptoms of
MECP2 DS should be attributed to gain of MeCP2
function.
Family study showed the mother and maternal grand-
mother also carried the MECP2 duplication. The patient
inherited the mutation from them. FISH test on the
mother showed the duplicated MECP2 gene was located
at X chromosome. However, the mother and the mater-
nal grandmother were asymptomatic. Further XCI study
showed the XCI pattern was non-random in both of
them. The ratio was 80:20 and 74:26 respectively. The X
chromosome carrying the duplication was prioritized in-
active. This molecular phenomenon may explain their
asymptomatic phenotype. In the previous reports, almost
all the asymptomatic carriers were with a skewed XCI
except one with XCI ratio 43:57 [27]. However, the XCI
ratio in peripheral blood DNA may not represent the ra-
tio in Brain. It could be inconsistent in different tissues.
A mother of a MECP2 DS patient had mild learning dif-
ficulties with a complete skewed XCI in the blood DNA
while the ratio was 74:26 in her hair roots. The authors
speculated that the inactivation of X chromosome with
MECP2 duplication in her brain was not completely
leading to her mild clinical features [28]. This is the only
literature about XCI test performed on the other tissue
rather than blood in patients with MECP2 DS. In this
family, two maternal uncles of the boy had severe devel-
opmental delay, severe mental retardation and recurrent
infections. Both of them died at young age. They were
highly suspected to be patients with MECP2 DS.
Conclusions
In this study, we demonstrate one more Chinese family
with MECP2 duplication syndrome. The main clinical fea-
tures include early onset hypotonia, mental retardation,
recurrent respiratory tract infections, limited speech and
dysmorphism. Female carrying the MECP2 duplication
could be asymptomatic due to the skewed XCI. In order
to make an accurate diagnosis and provide a right genetic
counseling, genomic structure rearrangement, especially
MECP2 duplication should be tested in the patients with
the above symptoms as well as other family members.
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